Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673880 · ClinicalTrials.gov registry record · Phase 1
Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT01673880 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 40 participants.
The verdict
NCT01673880, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a single-center, open-label, randomized crossover study being conducted in three cohorts of healthy adult subjects. Approximately 36 subjects will be randomized to one of three cohorts (approximately 12 subjects per cohort) and they will receive both a single dose of E2006 in capsule formulation and a single dose of E2006 in tablet formulation, in random sequence, at a 1:1 ratio. The doses to be tested will be 2.5 mg, 10 mg, and 25 mg.
Interventions
- DRUG E2006
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-08 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01673880
The ClinicalTrials.gov registry entry for NCT01673880 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which E2006 is the first listed.
NCT01673880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01673880 about?
NCT01673880 is a clinical study titled "Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations". This is a single-center, open-label, randomized crossover study being conducted in three cohorts of healthy adult subjects. Approximately 36 subjects will be randomized to one of three cohorts (approximately 12 subjects per cohort) and they will receive both a single dose of E2006 in capsule formula...
What is the current status of trial NCT01673880?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2012-08. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01673880?
The interventions under investigation include: E2006 (DRUG).
Who is sponsoring clinical trial NCT01673880?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.